You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
麗珠醫藥(01513.HK):麗珠生物取得新營業執照
格隆匯 01-18 22:28

格隆匯 1 月 18日丨麗珠醫藥(01513.HK)公吿,2021年1月15日,麗珠生物已辦理完畢其股東變更和註冊資本增加的商事變更登記備案工作並取得新的《營業執照》。本次變更完成後,麗珠生物的股東變更為公司、健康元及海南麗生聚源投資合夥企業(有限合夥),麗珠生物的註冊資本增加至人民幣666.666667百萬元。

為實現單抗收購事項,於2021年1月18日,麗珠生物與麗珠香港簽訂了股權轉讓協議。據此,麗珠香港同意轉讓而麗珠生物同意收購麗珠單抗100%的股權,代價為人民幣14.8億元,麗珠生物將承接未實繳出資部分的出資義務。

單抗收購事項工商變更登記完成後3個月內,麗珠生物將股權轉讓協議約定的全部股權轉讓款支付至麗珠香港指定的銀行帳户;雙方另行協商一致在其他時間支付的除外。單抗收購事項完成後,麗珠單抗將由麗珠生物直接持有100.00%。

重組實施還需根據各方後續簽署的相關文件逐步落實和推進,受市場環境變化、監管環境變化或不可抗力等因素影響,後續實施過程中存在一定的不確定性,完成情況取決於工商變更登記、銀行付匯程序、境外減資程序等完成時間。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account